Abstract

The ability of its four heterogeneous nuclear RNP-K-homology (KH) domains to physically associate with oncogenic mRNAs is a major criterion for the function of the coding region determinant-binding protein (CRD-BP). However, the particular RNA-binding role of each of the KH domains remains largely unresolved. Here, we mutated the first glycine to an aspartate in the universally conserved GXXG motif of the KH domain as an approach to investigate their role. Our results show that mutation of a single GXXG motif generally had no effect on binding, but the mutation in any two KH domains, with the exception of the combination of KH3 and KH4 domains, completely abrogated RNA binding in vitro and significantly retarded granule formation in zebrafish embryos, suggesting that any combination of at least two KH domains cooperate in tandem to bind RNA efficiently. Interestingly, we found that any single point mutation in one of the four KH domains significantly impacted CRD-BP binding to mRNAs in HeLa cells, suggesting that the dynamics of the CRD-BP-mRNA interaction vary over time in vivo. Furthermore, our results suggest that different mRNAs bind preferentially to distinct CRD-BP KH domains. The novel insights revealed in this study have important implications on the understanding of the oncogenic mechanism of CRD-BP as well as in the future design of inhibitors against CRD-BP function.

Highlights

  • Coding region determinant-binding protein (CRD-BP) interacts physically with oncogenic mRNAs

  • Cumulative evidence from studies in vitro and in cell lines suggests that the ability to physically interact with a subset of mRNAs plays a significant part in the function of CRD-BP and its orthologs

  • In vitro and granule formation studies in mammalian cells using CRD-BP orthologs have shown that the KH domains, and not the RNA recognition motifs (RRM) domains, are directly involved in binding RNA substrates (19, 20)

Read more

Summary

Background

Coding region determinant-binding protein (CRD-BP) interacts physically with oncogenic mRNAs. Results: Point mutation in the K-homology (KH) domains of CRD-BP abolishes its RNA-binding ability. The ability of its four heterogeneous nuclear RNP-K-homology (KH) domains to physically associate with oncogenic mRNAs is a major criterion for the function of the coding region determinantbinding protein (CRD-BP). CRD-BP has recently been shown to bind to the coding region of ␤-catenin (13) and GLI1 mRNAs (12) to stabilize the transcripts, providing further evidence for the role of CRD-BP in the Wnt/␤-catenin signaling pathway. We use site-directed mutagenesis to mutate the first Gly residue in each of the GXXG motifs in the KH domains of CRD-BP as an approach to understand to what degree each of the four domains are involved in binding to RNA substrates in vitro and in cells. Our results reveal important insights into how CRD-BP physically associates with its RNA-binding partners

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call